Insights on seed-stage fundraising, VC meetings, and startup evaluation.
A pre-revenue startup has no sales to multiply, so no formula sets its value. This guide explains the methods investors actually use, the Berkus, Scorecard, Risk Factor Summation, and Venture Capital methods, how each one really prices risk, why your number is usually a SAFE cap rather than a calculated price, and the three forces that decide it: your team, the market cycle, and the proof you bring before the conversation starts.
Pre-money is what the company is worth before new capital lands. Post-money is what it is worth after. The difference decides how much of your company you keep. This guide walks through the math, the SAFE switch that quietly transferred dilution risk from investors to founders, and what investors actually see when they read your cap table at the seed stage.
Pre-seed funding in 2026 means raising $250K to $1M on a post-money SAFE, with median valuation caps at $10M for smaller rounds and $15M for rounds above $1M. This guide covers the 2025 Carta benchmarks, what pre-seed investors actually look for beyond the pitch deck, SAFE mechanics and common mistakes, the warm intro vs cold outreach gap, and a 10-item pre-fundraise proof checklist for first-time founders. Built from 7 years on the investor side of the table.
The median seed pre-money valuation hit $16M in Q3 2025, up 14% year over year (Carta). The median post-money rose to $24M in Q4 2025. Behind those numbers sits a process most founders misread. Investors do not calculate valuation. They work backward from fund math and forward from proof. This guide explains the four valuation methods you will encounter, why decks lose pricing power, and how founders close at the top of their range.